Status:

COMPLETED

Antitussive Effect of Single-dose Dexmedetomidine With Low-dose Remifentanil Infusion

Lead Sponsor:

Yonsei University

Conditions:

Thyroidectomy

Eligibility:

All Genders

20-65 years

Phase:

PHASE4

Brief Summary

After thyroid surgery, the incidence and severity of coughing is important because it may cause serious complications, such as bleeding in the surgical field, laryngospasm, and cardiovascular disturba...

Eligibility Criteria

Inclusion

  • Thyroid disease undergoing thyroidectomy
  • age 20-65
  • Amerian society of anesthesgiologist class 1 or 2

Exclusion

  • chronic cough
  • difficult intubation
  • liver disease
  • uncontrolled hypertension

Key Trial Info

Start Date :

February 1 2014

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2015

Estimated Enrollment :

168 Patients enrolled

Trial Details

Trial ID

NCT02208505

Start Date

February 1 2014

End Date

December 1 2015

Last Update

October 18 2017

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Gangnam severance hospital

Seoul, South Korea, 135-720